Workflow
乙醇梭菌蛋白
icon
Search documents
中央一号文件点名!生物制造迎历史性机遇,这些企业率先入局!
Xin Lang Cai Jing· 2026-02-06 11:20
Core Insights - The 2026 Central Document emphasizes the integration of artificial intelligence with agriculture, promoting the development of agricultural bio-manufacturing as a new productive force [1][3][11] Group 1: Agricultural Bio-Manufacturing - Agricultural bio-manufacturing is expected to break the limitations of traditional agriculture, allowing for production that does not rely on climate or land resources [4][12] - Technologies such as molecular breeding, precision breeding, and gene editing can transform seeds, enabling the production of high-quality agricultural products in various regions [12][14] - The development of bio-manufacturing is crucial for ensuring food security in China, particularly in addressing the low self-sufficiency rate of soybeans, which is below 20% [4][12] Group 2: Technological Advancements - The integration of AI in agriculture is shifting practices from experience-based farming to data-driven management, enhancing efficiency through algorithms [3][11] - The transition to industrialized cell factory models in agriculture is significant for sustainable development, as demonstrated by the efficiency of bio-manufacturing processes [14] Group 3: Industry Initiatives - The first national agricultural bio-manufacturing innovation consortium was established in July 2025, led by major companies and research institutions [15] - Notable companies involved in agricultural bio-manufacturing include Dabeinong, Angel Yeast, and Meihua Biological, among others, which have products recognized in the first batch of bio-manufacturing landmark products [15][17]
央视报道:我国生物制造产业规模达1.1万亿元!
Core Viewpoint - During the "14th Five-Year Plan" period, China's bio-manufacturing industry has experienced significant growth, becoming a crucial force for optimizing and upgrading the economic structure, with a total scale reaching 1.1 trillion yuan [2][3]. Industry Overview - The bio-manufacturing industry in China has steadily expanded, achieving a total scale of 1.1 trillion yuan, with bio-fermentation products accounting for over 70% of global production [3][4]. - The annual output value of sub-sectors such as food additives and biopharmaceuticals exceeds 400 billion yuan, establishing bio-manufacturing as a new economic growth point [3][4]. Technological Innovation - China's bio-manufacturing sector holds over 20% of global patent applications, with the establishment of several national key laboratories and industrial innovation platforms [4]. - New instruments such as domestic high-throughput gene sequencers and large-scale fermentation tanks have been successfully industrialized [4]. Industrial Cluster Development - Regions like Beijing and Tianjin have emerged as innovation hubs for bio-manufacturing, while provinces such as Shandong, Heilongjiang, and Henan have developed into major manufacturing bases for bulk bio-fermentation products [5]. - The "14th Five-Year Plan" has fostered the growth of numerous backbone enterprises with annual revenues exceeding 10 billion yuan, along with the emergence of several national-level manufacturing champions and specialized "little giant" enterprises [5]. Policy and Recognition - The Ministry of Industry and Information Technology (MIIT) has released a list of 35 landmark bio-manufacturing products, with companies like New Hope Liuhe, Blue Crystal Microbiology, and Huaxi Biological among the applicants [6][8].
山东三项入选!工信部首批生物制造标志性产品公布
Da Zhong Ri Bao· 2025-12-20 02:49
Core Viewpoint The Ministry of Industry and Information Technology has organized a collection of landmark products in the field of biomanufacturing to enhance the integrated development capabilities of "technology research and development - production - market promotion" [1][10]. Group 1: Landmark Products - The first batch of 35 selected products includes hyaluronic acid from Shandong Huaxi Biotechnology Co., glucosamine from Shandong Runde Biotechnology Co., and trans-aconitic acid from the Qingdao Institute of Bioenergy and Process Research, Chinese Academy of Sciences [1][7]. - The selected products span various fields such as food additives, biopharmaceuticals, and biobased chemicals, showcasing advanced technology and significant economic benefits [9][10]. Group 2: Product Details - Ethanol clostridial protein, produced by Beijing Shoulang Biotechnology Co., is a beneficial supplement to existing feed proteins, utilizing industrial waste gases as nutrients for microbial fermentation [2]. - Altritol, produced by Huiguan Synthetic Biotechnology (Beijing) Co., is a low-calorie sweetener derived from microbial fermentation, significantly improving production efficiency [2]. - PHA (polyhydroxyalkanoate), a biodegradable polymer, is produced by Shanghai Yingjing Microbial Technology Co. and can replace plastics, reducing "white pollution" [6]. Group 3: Production Innovations - The products utilize innovative fermentation processes and engineered strains to enhance production efficiency and reduce costs, such as the use of engineered E. coli for L-alanine production [6][9]. - The Ministry plans to establish a biomanufacturing landmark product database to promote these products and support their technological innovation and market capabilities [9][10].
北京替代蛋白创新发展论坛举办
Huan Qiu Wang· 2025-11-06 08:00
Core Insights - The "Beijing Alternative Protein Innovation and Development Forum" aims to explore high-quality development paths for the alternative protein industry, gathering various stakeholders to foster collaboration and consensus [1][2] Group 1: Industry Development - The forum featured key speakers sharing insights on the development of the alternative protein industry, emphasizing the integration of academic research and practical applications [1] - Beijing's development plan for alternative protein includes specific goals and implementation pathways, as presented by local government officials [2] - The establishment of the "Agricultural Zhongguancun Alternative Protein Research Institute" aims to provide foundational technological support for the industry [1][2] Group 2: Practical Implementation - The forum showcased practical initiatives, including the "Alternative Protein Action Plan" which outlines policy guidance for industry development [2] - The "Agricultural Zhongguancun New Quality Protein Resource Exploration and Utilization Research Institute" is positioned as a bridge for resource development and industry collaboration [2] - Innovative projects such as the "Green Low-Carbon Biological Manufacturing of Ethanol Clostridium Protein" were presented, highlighting new technological avenues for alternative protein production [2] Group 3: Collaborative Efforts - A roundtable discussion focused on actionable strategies for developing the alternative protein industry in Beijing, with industry experts sharing experiences and addressing challenges [3] - A partnership agreement was signed between Beijing University of Commerce and several companies to establish a new quality protein research and training base, integrating academic and industrial resources [3] - The forum outlined a comprehensive development blueprint for the alternative protein industry, reinforcing confidence in collaborative efforts for high-quality growth [3]
工信部公示,新和成、凯赛生物等首批36家入选
DT新材料· 2025-07-31 16:05
Core Viewpoint - The Ministry of Industry and Information Technology of China has officially announced the first batch of "Biomanufacturing Iconic Products," which includes 36 products from various companies, marking a significant step in technological innovation and industrial upgrading in the biomanufacturing sector [1]. Summary by Relevant Sections Biomanufacturing Iconic Products - The list includes 36 companies such as Beijing Shulang Biotechnology, Micro Yuan Synthesis, and Qilu Pharmaceutical, showcasing the diversity and innovation within the biomanufacturing industry [1]. - The products range from biopharmaceuticals to food additives, indicating a broad application of biomanufacturing technologies across different sectors [1]. Notable Products - Ethanol Clostridium protein produced by Beijing Shulang is a feed protein supplement derived from microbial fermentation using industrial waste gases [4]. - Alotose, produced by Micro Yuan Synthesis, is a low-calorie sweetener that enhances production efficiency through microbial fermentation [4]. - Polyhydroxyalkanoate (PHA) from Beijing Microstructure is a biodegradable material that can replace plastics, reducing environmental pollution [4]. - CAR-T cell therapy product, Nakiolun, developed by Huyuan Biotechnology, shows significant advancements in cancer treatment [4]. - Various other products include natural extracts, amino acids, and vaccines, highlighting the innovative approaches in biomanufacturing [4][5][6][7]. Industry Significance - The announcement reflects the government's commitment to promoting the biomanufacturing industry, which is crucial for technological advancement and economic growth [1]. - The diversity of products indicates a growing trend towards sustainable and environmentally friendly manufacturing practices within the industry [1].
36项!工信部公示首批生物制造标志性产品名单,有哪些企业?
Core Viewpoint - The Ministry of Industry and Information Technology of China has officially announced the "First Batch of Iconic Products in Biological Manufacturing," which includes 36 products, marking a significant step in technological innovation and industrial upgrading in the biological manufacturing sector [1][3]. Summary by Sections Iconic Products List - The list includes 36 companies such as: - Shoulang Biotechnology - Micro元合成 - KaiLaiYing - Qinhongdao Huaheng Biotechnology - Qilu Pharmaceutical - JinSai Pharmaceutical - And others [3][5]. Product Details - Each product listed has specific applications and innovations: - **Ethanol Clostridium Protein**: Produced from industrial waste gases, beneficial for animal feed [5]. - **Alotose**: A low-calorie sweetener produced through microbial fermentation, enhancing production efficiency [5]. - **Nakiol Injection**: A CAR-T cell therapy for treating acute lymphoblastic leukemia, showing improved safety and efficacy [5]. - **Vitamin B**: Produced via fermentation, offering higher efficiency compared to traditional extraction methods [7]. - **Recombinant Human Serum Albumin**: Produced using rice cell technology, meeting clinical needs effectively [9]. Industry Significance - The announcement reflects the government's strong emphasis on the development of the biological manufacturing industry, showcasing the potential for innovation and growth in this sector [1][3]. Upcoming Events - The "SynBioCon 2025" conference will be held from August 20-22, focusing on AI in biological manufacturing, green chemistry, and future food and agriculture [11][12].